Ribosome and translation machinery

The ribosome and translation machinery in antigen-presenting cells (APCs) comprise the complex assembly of ribosomal subunits (40S and 60S), messenger RNA, transfer RNA, and various translation initiation, elongation, and termination factors. In the immune system, this machinery is essential for the synthesis of proteins that are processed into antigenic peptides for presentation on Major Histocompatibility Complex (MHC) molecules, a process vital for T-cell activation (Yewdell, 2011). This system is the primary effector for mRNA-based vaccines, where the APC's translational apparatus is leveraged to produce specific antigens in situ (Sahin et al., 2014). Furthermore, the regulation of this machinery by the mTOR signaling pathway determines the metabolic and functional state of APCs, influencing their maturation and cytokine production (He et al., 2013). Therapeutic strategies targeting this system include mRNA therapeutics for immunization and small-molecule inhibitors of translation or its regulatory pathways for treating malignancies and immune-mediated disorders. Monitoring translation activity in these contexts often involves assessing the phosphorylation status of downstream effectors like S6 ribosomal protein or 4E-BP1 (Pelletier et al., 2015).

Other names

Protein synthesis machineryTranslational apparatusRibosomal complexTranslation systemRibosomes and translation machinery in antigen-presenting cells

Translation of therapeutic mRNA into antigenic proteins to elicit an immune response; inhibition of the ribosomal peptidyl transferase center to prevent protein synthesis; modulation of translation initiation via mTOR pathway inhibition.